Phase 3 Readout~month

Phase 3 Topline: A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Sa

Indication
Immunoglobulin A Nephropathy

Other upcoming events for TVTX

Phase 1 StartPhase 1 Start: A Single Dose, Randomized, Open-label, Two-way Crossover Food-effect Bioavailbility Study of Fixed D
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Parallel-Group Treatment, Blinded, Randomized, Placebo-Controlled Study To Assess The Eff
Phase 3 ReadoutPhase 3 Topline: The University of Ottawa Dapagliflozin in STEMI Randomized Clinical Trial
Phase 3 ReadoutPhase 3 Topline: Dapagliflozin for Long COVID Syndrome
Phase 3 ReadoutPhase 3 Topline: REVERsal to Normoglycemia by Treating PREDIABETES: The REVERT-PREDIABETES Trial

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Sa — TVTX Phase 3 Readout | BioSniper